Nuclear receptor coregulators and human disease

被引:230
作者
Lonard, David M. [1 ]
Lanz, Rainer B. [1 ]
O'Malley, Bert W. [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
10.1210/er.2007-0012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nuclear receptor (NR) coregulators (coactivators and corepressors) are essential elements in regulating nuclear receptormediated transcription. In a little more than a decade since their discovery, these proteins have been studied mechanistically and reveal that the regulation of transcription is a highly controlled and complex process. Because of their central role in regulating NR-mediated transcription and in coordinating intercompartmental metabolic processes, disruptions in coregulator biology can lead to pathological states. To date, the extent to which they are involved in human disease has not been widely appreciated. In a complete literature survey, we have identified nearly 300 distinct coregulators, revealing that a great variety of enzymatic and regulatory capabilities exist for NRs to regulate transcription and other cellular events. Here, we substantiate that coregulators are broadly implicated in human pathological states and will be of growing future interest in clinical medicine. ( Endocrine Reviews 28: 575-587, 2007)
引用
收藏
页码:575 / 587
页数:13
相关论文
共 112 条
[1]   A systems approach to clinical oncology: Focus on breast cancer [J].
Abramovitz, Mark ;
Leyland-Jones, Brian .
PROTEOME SCIENCE, 2006, 4 (1)
[2]   Androgen-insensitivity syndrome as a possible coactivator disease [J].
Adachi, M ;
Takayanagi, R ;
Tomura, A ;
Imasaki, K ;
Kato, S ;
Goto, K ;
Yanase, T ;
Ikuyama, S ;
Nawata, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (12) :856-862
[3]   A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[4]   The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle [J].
Arany, Zoltan ;
Lebrasseur, Nathan ;
Morris, Carl ;
Smith, Eric ;
Yang, Wenli ;
Ma, Yanhong ;
Chin, Sherry ;
Spiegelman, Bruce M. .
CELL METABOLISM, 2007, 5 (01) :35-46
[5]   THE TAU-4 ACTIVATION DOMAIN OF THE THYROID-HORMONE RECEPTOR IS REQUIRED FOR RELEASE OF A PUTATIVE COREPRESSOR(S) NECESSARY FOR TRANSCRIPTIONAL SILENCING [J].
BANIAHMAD, A ;
LENG, XH ;
BURRIS, TP ;
TSAI, SY ;
TSAI, MJ ;
OMALLEY, BW .
MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) :76-86
[6]   Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma [J].
Barr, FG .
ONCOGENE, 2001, 20 (40) :5736-5746
[7]   Resveratrol improves health and survival of mice on a high-calorie diet [J].
Baur, Joseph A. ;
Pearson, Kevin J. ;
Price, Nathan L. ;
Jamieson, Hamish A. ;
Lerin, Carles ;
Kalra, Avash ;
Prabhu, Vinayakumar V. ;
Allard, Joanne S. ;
Lopez-Lluch, Guillermo ;
Lewis, Kaitlyn ;
Pistell, Paul J. ;
Poosala, Suresh ;
Becker, Kevin G. ;
Boss, Olivier ;
Gwinn, Dana ;
Wang, Mingyi ;
Ramaswamy, Sharan ;
Fishbein, Kenneth W. ;
Spencer, Richard G. ;
Lakatta, Edward G. ;
Le Couteur, David ;
Shaw, Reuben J. ;
Navas, Placido ;
Puigserver, Pere ;
Ingram, Donald K. ;
de Cabo, Rafael ;
Sinclair, David A. .
NATURE, 2006, 444 (7117) :337-342
[8]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[9]   Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer [J].
Bernig, Toralf ;
Chanock, Stephen J. .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2006, 6 (03) :319-331
[10]   Decreased hepatic expression of PPAR-γ coactivator-1 in cholesterol cholelithiasis [J].
Bertolotti, M ;
Gabbi, C ;
Anzivino, C ;
Mitro, N ;
Godio, C ;
De Fabiani, E ;
Crestani, M ;
Del Puppo, M ;
Ricchi, M ;
Carulli, L ;
Rossi, A ;
Loria, P ;
Carulli, N .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (03) :170-175